US Edition
New Hope for Epidermolysis Bullosa: Tampere University Licenses Promising Drug to Theravia – Patient Worthy
Summary by Patient Worthy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
New Hope for Epidermolysis Bullosa: Tampere University Licenses Promising Drug to Theravia – Patient Worthy
A significant step forward in the treatment of a rare and painful skin condition has emerged from Finland. According to News Medical Life Sciences, Tampere University has announced the licensing of a new drug candidate for Epidermolysis Bullosa (EB) to the biopharmaceutical company Theravia. This move marks a promising advance for patients suffering from the […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
